Effect of PAO (phenylarsine oxide) on the inhibitory effect of insulin and IGF-1 on insulin release from INS-1 cells

Endocrine Journal

Volumn 53, Issue 1, 2006, Pages 21-26

  Verspohl, Eugen J ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Dimercaptopropanol; GLUT2; Inhibition of insulin release; INS 1 cells; Phenylarsine oxide

Indexed keywords

ARSENOSOBENZENE; DIMERCAPROL; GLUCOSE TRANSPORTER 2; INSULIN; SOMATOMEDIN C;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; HORMONAL REGULATION; INCUBATION TIME; INSULIN RELEASE; NONHUMAN; PROTEIN PROTEIN INTERACTION; RADIOIMMUNOASSAY; RAT; WESTERN BLOTTING;

ANIMALS; ARSENICALS; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE; DIMERCAPROL; DRUG INTERACTIONS; FEEDBACK, BIOCHEMICAL; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GLUCOSE TRANSPORTER TYPE 2; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, KNOCKOUT; RADIOIMMUNOASSAY; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 33644993314     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.53.21     Document Type: Article

References (29)

1. Quentmeier A, Klein H, Unthan-Fechner K, Probst I (1993) Attenuation of insulin actions in primary rat hepatocyte cultures by phenylarsine oxide. Biol Chem Hoppe-Seyler 374: 965-971.
2. Trowbridge M, Draznin B (1986) Insulin internalization and intracellular protein degradation: a quantitative correlation. Horm Metab Res 18: 156-158.
3. Knutson VP, Ronnett GV, Lane MD (1983) Rapid, reversible internalisation of cell surface insulin receptors. Correlation with insulin-induced down-regulation. J Biol Chem 258: 12139-12142.
4. Douen AG, Jones MN (1988) The action of phenylarsine oxide on the stereospecific uptake of D-glucose in basal and insulin-stimulated rat adipocytes. Biochim Biophys Acta 968: 109-118.
5. Douen AG, Jones MN (1989) Insulin processing and signal transduction in rat adipocytes. BBA 1010: 363-368.
6. Bernier M, Laird DM, Lane MD (1988) Effect of vanadate on the cellular accumulation of pp15, an apparent product of insulin receptor tyrosine kinase action. J Biol Chem 263: 13626-13634.
7. Balloti R, Tartare S, Chauvel A, Scimeca JC, Alengrin F, Filloux C, Van Obberghen E (1991) Phenylarsine oxide stimulates a cytosolci trosine kinase activity and glucose transport in mouse fibroblasts. Exp Cell Res 197: 300-306.
8. Frost SC, Kohanski RA, Lane MD (1987) Effect of phenylarsine oxide on insulin-dependent protein phosphorylation and glucose transport in 3T3-L1 adipocytes. J Biol Chem 262: 9872-9876.
9. Carey JO, Azevedo JL, Morris PG, Pories WJ, Dohm GL (1995) Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin - resistant human skeletal muscle. Diabetes 44: 682-688.
10. Begum N (1994) Phenylarsine oxide inhibits insulin-stimulated protein phosphatase 1 activity and GLUT 4 translocation. Am J Physiol 267: E14-E23.
11. Frost SC, Lane MD (1985) Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem 260: 2646-2652.
12. Frost SC, Schwalbe MS (1990) Uptake and binding of radiolabelled phenylarseine oxide in 3T3-L1 adipocytes. Biochem J 269: 589-595.
13. Wang C, Hsieh C-H, Wu W-G (1991) Phenylarsine oxide inhibits insulin-dependent glucose transport activity in rat soleus muscles. BBRC 176: 201-206.
14. Jhun BH, Hah JS, Jung CY (1991) Phenylarsine oxide causes an insulin-dependent, GLUT-4 specific degradation in rat adipocytes. J Biol Chem 266: 22260-22265.
15. Henriksen EJ, Schneider MC, Ritter LS (1993) Regulation of contractile-stimulated system A amino acid uptake in skeletal muscle. Role of vicinal sulfhydryls. Metabolism 42: 440-445.
16. Pronk GJ, Medema RH, Burgering BM, Clark R, McCormick F, Bos JL (1992) Interaction between the p21ras GTPase activating protein and the insulin receptor. J Biol Chem 267: 24058-24063.
17. Han YP, Kohanski RA (1997) Phenylarsine oxide inhibits insulin activation of phosphatidylinositol 3′-kinase. BBRC 239: 316-321.
18. Sodoyez JC, SodoyezGoffaux F, Foa PP (1969) Evidence for an insulin-induced inhibition of insulin release by isolated islets of Langerhans. Proceedings of the Society for Experimental Biology and Medicine 130: 568-571.
19. Verspohl EJ, Händel M, Hagenloh I, Ammon HPT (1982) In vitro effect of exogenous insulin on insulin secretion. Studies with glucose, leucine, arginine, aminophylline and tolbutamide. Acta Diabetol Latina 19: 303-317.
20. Verspohl EJ, Händel M, Ammon HPT (1979) Pentose-phosphate shunt of rat pancreatic islets: Its dependence on glucose concentration. Endocrinology 105: 1269-1274.
21. Ammon HPT, Reiber C, Verspohl EJ (1991) Indirect evidence for short-loop negative feedback of insulin secretion in the rat. J Endocrin 128: 27-34.
22. Van Schravendijk CF, Foriers A, Van den Brande JL, Pipeleers DG (1987) Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology 121:1784-1788.
23. Van Schravendijk CF, Heylen L, Van den Brande JL, Pipeleers DG (1990) Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells. Diabetologia 33: 649-653.
24. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB (1992) Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130: 167-178.
25. Li J, Elberg G, Shechter Y (1996) Phenylarsine oxide and vanadate: apparent paradox of inhibition of protein phosphotyrosine phosphatases in rat adipocytes. BBA 1312: 223-230.
26. Scott DA, Fisher AM (1938) The insulin and the zinc content of normal and diabetic pancreas. J Clin Invest 17: 725.
27. Trautschold T, Löffler G, Ahrendt C (1968) Enzymaktivitäten des Glucosestoffwechsel in isolierten Langerhans'schen Inseln der Ratte. Herbsttagung Dt. Ges Biol Chemie Münster.
28. Bergmeyer HU (1974) Methoden der enzymatischen Analyse. Verlag Chemie, Weinheim 3. Auflage. page 256.
29. Lane MD, Flores-Riverso JR, Hresko RC, Kaestner KH, Liao K, Janicot M, Hoffman RD, McLenithan JC, Kastelic T, Christy RJ (1990) Insulin receptor tyrosine kinase and glucose transport. Diabetes Care 13: 565-575.